IRMA SANTAMARIA: Open Payments
NPI 1881371557 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,281 in 60 payments from 15 companies in 2025. Trend: 2023 $89 · 2024 $1,375 · 2025 $1,281
Food & beverage: $1,281
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $308 |
| Novo Nordisk Inc | 14 | $189 |
| Astellas Pharma US Inc | 6 | $175 |
| Lilly USA, LLC | 14 | $162 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Merck Sharp & Dohme LLC | 2 | $73 |
| Corcept Therapeutics | 2 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Abbott Laboratories | 2 | $44 |
| ABBVIE INC. | 1 | $29 |
Products named: BREZTRI, Veozah, Wegovy, MOUNJARO, TRELEGY ELLIPTA, AIRSUPRA, JARDIANCE, Korlym.
Industry payments across AZ — which companies pay providers there.
